Galactorrhea and Hyperprolactinemia in Schizophrenic Patients on Neuroleptics: Frequency and Etiology
The DOI matches its Crossref record.
Abstract
The frequency of galactorrhea and the subjective response to it were investigated in 150 schizophrenic patients. The incidence rate was 14% and the prevalence rate 19%. The latency periods between start of neuroleptic medication and manifestation of galactorrhea were subject to substantial scatter, as were the prolactin values. Patients who had undergone neuroleptic relapse prevention prior to the index episode and/or had been pregnant were affected significantly more frequently by galactorrhea.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Physical Health Monitoring of Patients With Schizophrenia
Marder, S. R., Essock, S. M., Miller, A. L., Buchanan, R. W., Casey, D. E., Davis, J. M., Kane, J. M., Lieberman, J. A., Schooler, N. R., Covell, N., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.8.1334 · Cited by 812
Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review
Ochoa, S., Usall, J., Cobo, J., Labad, X., & Kulkarni, J. (2012) · Schizophrenia Research and Treatment · doi:10.1155/2012/916198 · Cited by 735
“For example, in one study which included 150 women, 14% were observed to develop galactorrhea within 75 days of initiating treatment with conventional antipsychotics [85].”
BackgroundPhysical illness and schizophrenia: a review of the literature
Leucht, S., Burkard, T., Henderson, J., Maj, M., & Sartorius, N. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.01095.x · Cited by 633
“Therefore many patients suffer from prolactin-associated effects such as galactorrhea (131), and amenorrhea (132).”
BackgroundAntipsychotic-Induced Hyperprolactinaemia: Mechanisms, Clinical Features and Management
Haddad, P. M., & Wieck, A. (2004) · Drugs · doi:10.2165/00003495-200464200-00003 · Cited by 634
Kinon, B. J., Gilmore, J. A., Liu, H., & Halbreich, U. M. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00127-0 · Cited by 350
The Effects of Antipsychotic-Induced Hyperprolactinaemia on the Hypothalamic-Pituitary-Gonadal Axis
Smith, S., Wheeler, M. J., Murray, R., & O’Keane, V. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200204000-00002 · Cited by 202
Wieck, A., & Haddad, P. M. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.3.199 · Cited by 167
“It is more likely to occur in women who have had children and are of premenopausal age (Windgassen et al, 1996).”
Byerly, M., Suppes, T., Tran, Q.-V., & Baker, R. A. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815ac4e5 · Cited by 153
O'Keane, V. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088439 · Cited by 126
“LH and FSH determine normal follicular growth in females (Windgassen et al., 1996) and steroidogenesis and spermatogenesis in males (Yazigi et al., 1997).”
BackgroundHyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents
Naidoo, U., Goff, D. C., & Klibanski, A. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00129-4 · Cited by 113
“Galactorrhea was reported in as many as 57% of females treated with conventional agents, whereas gynecomastia infrequently occurs and galactorrhea rarely occurs in men (Robinson, 1957; Plante and Roy, 1967; Windgassen et al., 1996).”
BackgroundMontejo, Á. L., Arango, C., Bernardo, M., Carrasco, J. L., Crespo-Facorro, B., Cruz, J. J., del Pino, J., García Escudero, M. A., García Rizo, C., González-Pinto, A., et al. (2016) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2015.11.003 · Cited by 55
Metadata
- Authors
- Windgassen, K. W., Wesselmann, U., & Mönking, S.
- Venue
- Neuropsychobiology
- Publisher
- S. Karger AG
- Published
- 1996
- Volume
- 33
- Issue
- 3
- Pages
- 142-146
- ISSN
- 0302-282X (ISSN-L)
- 1423-0224
- OpenAlex
- W2028873973
- Cited by
- 67
- References
- 0
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.